No Cover Image

Journal article 63 views

Improving infant Neurocognitive Development and Growth Outcomes with micronutrients (INDiGO): A protocol for an efficacy trial in rural Gambia

Sophie E Moore Orcid Logo, Samantha McCann, Ousman Jarjou, Muhammed A Danjo Orcid Logo, Bakary Sonko Orcid Logo, Ebrima Sise, Samuel Beaton, Daniel Tod, Greg Fegan, Andrew M Prentice

Wellcome Open Research, Volume: 9, Start page: 377

Swansea University Authors: Daniel Tod, Greg Fegan

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.12688/wellcomeopenres.21282.1

Abstract

Undernutrition during the early years of life has a harmful and irreversible impact on child growth and cognitive development. Many of the interventions tested to improve outcomes across infancy have had disappointing or inconsistent impact, a common feature being the absence of any attempt to provi...

Full description

Published in: Wellcome Open Research
ISSN: 2398-502X
Published: F1000 Research Limited 2024
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa68101
Abstract: Undernutrition during the early years of life has a harmful and irreversible impact on child growth and cognitive development. Many of the interventions tested to improve outcomes across infancy have had disappointing or inconsistent impact, a common feature being the absence of any attempt to provide nutritional supplements to infants during the first six months. With increasing evidence of micronutrient deficiencies in this age group, alongside strong evidence that growth and developmental deficits begin before six months, a renewed focus on the micronutrient status of infants is required. This study is a five-arm, double-blind, placebo-controlled, randomised efficacy trial of micronutrient supplementation to mothers (during pregnancy or pregnancy and lactation) and infants (Day 8 to six months of age) in rural Gambia, where rates of micronutrient deficiencies are high. 600 pregnant women (<20 weeks gestation) will be enrolled into one of five trial arms and followed to 12 months post-partum. The primary outcome will be infant brain development at six months, with micronutrient status, growth and neurocognitive development to 12 months as secondary outcomes. This novel research will identify the most efficacious way of improving micronutrient status in infancy, and assess impact on infant developmental outcomes, providing an evidence base for future effectiveness trials and policy recommendations. ISRCTN registry ( ISRCTN15063705, 09/07/2021); Pan African Clinical Trials Registry ( PACTR202201552774601, 21/01/2022). [Abstract copyright: Copyright: © 2024 Moore SE et al.]
Item Description: Study protocol
Keywords: Micronutrients, pregnancy, lactation, infancy, neurodevelopment, growth, intervention, Gambia
College: Faculty of Medicine, Health and Life Sciences
Funders: The INDiGO trial is funded by Wellcome, through a Senior Research Fellowship to the lead author (SEM; grant reference 220225). The trial will benefit from the infrastructure already in place at MRCG which is funded by the UK Medical Research Council (MRC) and the Department for International Development (DFID) under the MRC/DFID Concordat agreement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Start Page: 377

Similar Items